Picture of PAVmed logo

PAVM — PAVmed News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

PAVmed Inc reports results for the quarter ended in June - Earnings Summary

* PAVmed Inc  PAVM.OQ  reported a quarterly adjusted loss
of 14
cents​​ per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 19 cents per share.
    * Revenue was $166.00 thousand​; analysts expected $525.00
thousand. 
    * PAVmed Inc's reported EPS for the quarter was a loss of 14
cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * PAVmed Inc shares had fallen by 20.0% this quarter and
lost 32.1% so far this year.
    * The company reported a quarterly loss of $14.61 million.
    * Wall Street's median 12-month price target for PAVmed Inc
is
$1.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 15 at 07:08 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.19          -0.14          Beat
 Mar. 31 2023      -0.21          -0.19          Beat
 Dec. 31 2022      -0.25          -0.23          Beat
 Sep. 30 2022      -0.26          -0.29          Missed

Recent news on PAVmed

See all news